Venn Life Sciences - part of hVIVO plc · 1 month ago
Business Development Director ( CRO, Clinical Site Services )
hVIVO is a rapidly growing specialist Contract Research Organisation and the global leader in human challenge studies. They are seeking an experienced Business Development Director to drive sales of clinical site services, lab services, and human challenge trials, particularly focusing on clients across Northern Europe.
BiotechnologyClinical TrialsHealth CareMedical
Responsibilities
Develop and execute a sales strategy for clinical site and lab services, ensuring alignment with hVIVO’s growth objectives
Proactively identify, prospect, and engage new clients in the pharmaceutical and biotechnology sectors
Build and maintain strong relationships with key accounts, ensuring long-term client satisfaction and repeat business
Manage the full business development cycle from lead generation to contract signature
Represent hVIVO at industry conferences and networking events, promoting our capabilities and identifying new opportunities
Host client visits and conduct off-site client meetings as needed
Collaborate closely with Business Operations, and other Commercial functions to ensure smooth delivery and client alignment
Provide accurate, timely updates to the BD opportunity pipeline and sales forecasts
Qualification
Required
Proven track record of business development in clinical research, CRO services, or life sciences (essential)
Strong network within the pharmaceutical and biotechnology sectors in Europe
Experience selling complex clinical or laboratory services, ideally Phase I or challenge trial-related
Excellent communication, negotiation, and relationship-building skills
Fluency in English required
Results-driven, self-motivated, and comfortable working independently in a fast-paced, growth-oriented environment
Preferred
Proficiency in German, French, or another European language highly desirable
Company
Venn Life Sciences - part of hVIVO plc
Venn Life Sciences - part of hVIVO plc is an Integrated Drug Development partner offering an unique combination of drug development consultancy, clinical trial design and execution, enabling us to create, plan and execute drug development programmes effectively for our customers.
Funding
Current Stage
Public CompanyTotal Funding
$0.86M2018-07-04Post Ipo Equity· $0.86M
2012-12-18IPO
Company data provided by crunchbase